FundedIQ
Biotechnology

Joint Academy: Funding, Investors & Team (Sep 2026)

Joint Academy is a digital clinic for people with osteoarthritis. We are pioneering software-as-a-medicine for osteoarthritis, re-thinking and transforming how people get diagnosed and treatment for the chronic disease. Our product approaches healthcare with real science (clinical evidence) primed by objective data (machine-learning) to deliver the best outcome for healthy joints. For the hardest-to-treat conditions we simply believe we have to go beyond pills and surgery.

www.jointacademy.com LinkedIn Malmö, Sweden 11-50 employees
Biotechnology Health Care Health Diagnostics Medical Medical Device Software Therapeutics
Total raised
$23.0M
Rounds
1
Latest
Undisclosed round
Sep 2020

Joint Academy has raised $23.0M across 1 funding round on record, the most recent an undisclosed round of $23.0M announced in Sep 2020.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Joint Academy Company Profile and Key Stats

Total funding raised
$23.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$23.0M in Sep 2020
Employees
11-50
reported band
Headquarters
Malmö, Sweden

Latest funding round on record: Sep 2020.

Joint Academy Funding Rounds

Date
Round
Amount
Undisclosed round
$23.0M

Joint Academy Founders and Leadership Team

Name
Role
Contact
Jakob Dahlberg
CEO
Locked

Contact details for the Joint Academy team: 1 of 1 has an email address on file.

Start 14-day free trial →

Joint Academy Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
688
$4.2M

Joint Academy's latest round of $23.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Joint Academy in Biotechnology and Malmö

Companies Similar to Joint Academy

Pixelgen Technologies, established in Sweden in 2020, focuses on the advancement of biomedical research and…

Series B $15.5M

Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic…

Undisclosed round $1.4M

Emulsi Biotech is a biotechnology company that develops lipid technology to deliver biologic drugs orally.

Pre-Seed $740k

Our vision is to develop and bring to the market safe and effective treatments for women specific diseases…

Undisclosed round $790k

OncoZenge is a Swedish pharmaceutical company. It develops better products for the supportive care of cancer…

Undisclosed round $1.6M

Elicera Therapeutics is a clinical stage immuno-oncology company developing cell and gene therapies for…

Undisclosed round $150k

Alligator Bioscience is an innovative research based biotech company focused on developing novel drugs for…

Undisclosed round $2.1M

Moleculent is dedicated to creating tech-based products that utilize fresh knowledge about the molecular…

Undisclosed round $20.0M

Bio-Works was established in 2006 and specializes in creating, producing, and distributing cutting-edge…

Undisclosed round $60k

Verigraft AB is a biotech company that creates personalized tissue-engineered transplants for use in…

Undisclosed round $11.9M

Lipum aims to eliminate or alleviate painful symptoms for millions of patients suffering from chronic…

Undisclosed round $9.3M

ArgusEye is a biotech firm that offers sensor solutions for instant identification of biological systems and…

Undisclosed round $7.4M

Joint Academy Funding FAQs

What does Joint Academy do?

Joint Academy is a digital clinic for people with osteoarthritis. We are pioneering software-as-a-medicine for osteoarthritis, re-thinking and transforming how people get diagnosed and treatment for the chronic disease. Our product approaches healthcare with real science (clinical evidence) primed by objective data (machine-learning) to deliver the best outcome for healthy joints. For the hardest-to-treat conditions we simply believe we have to go beyond pills and surgery.

How much funding has Joint Academy raised?

Joint Academy has raised $23.0M across 1 round on record. The most recent is an undisclosed round of $23.0M announced in Sep 2020.

When did Joint Academy last raise funding?

Joint Academy's most recent funding round on record is an undisclosed round of $23.0M, announced in Sep 2020.

Who is the CEO of Joint Academy?

Jakob Dahlberg is listed as CEO at Joint Academy.

Where is Joint Academy headquartered?

Joint Academy is based in Malmö, Skane Lan, Sweden.

How many employees does Joint Academy have?

Joint Academy is in the 11-50 employee band.

How does Joint Academy's funding compare to other Biotechnology startups?

Joint Academy's latest round of $23.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Joint Academy Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Joint Academy is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.